The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects - 28/03/23


Abstract |
Lipotoxicity is the dysregulation of the lipid environment and/or intracellular composition that leads to accumulation of harmful lipids and ultimately to organelle dysfunction, abnormal activation of intracellular signaling pathways, chronic inflammation and cell death. It plays an important role in the development of acute kidney injury and chronic kidney disease, including diabetic nephropathy, obesity-related glomerulopathy, age-related kidney disease, polycystic kidney disease, and the like. However, the mechanisms of lipid overload and kidney injury remain poorly understood. Herein, we discuss two pivotal aspects of lipotoxic kidney injury. First, we analyzed the mechanism of lipid accumulation in the kidney. Accumulating data indicate that the mechanisms of lipid overload in different kidney diseases are inconsistent. Second, we summarize the multiple mechanisms by which lipotoxic species affect the kidney cell behavior, including oxidative stress, endoplasmic reticulum stress, mitochondrial dysfunction, dysregulated autophagy, and inflammation, highlighting the central role of oxidative stress. Blocking the molecular pathways of lipid accumulation in the kidney and the damage of the kidney by lipid overload may be potential therapeutic targets for kidney disease, and antioxidant drugs may play a pivotal role in the treatment of kidney disease in the future.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | The mechanisms by which FABP1 and FABP4 mediate lipid accumulation are inconsistent in kidney disease. |
• | Lipid accumulation plays an important role in the progression of kidney disease, and the mechanism of lipid accumulation varies with the etiology of kidney disease. |
• | Oxidative stress may lie at the heart of lipotoxic kidney injury. |
• | The prospect of improving lipid metabolism as a treatment for kidney disease is underlined. |
• | Blocking lipid overload and renal injury from molecular mechanisms perspective may provide new promising therapeutic interventions for the treatment of kidney disease. |
Abbreviations : KD, AKI, CKD, DN, ORG, PKD, FFA, FA, CD36, FATP, FABP, LCFA, TEC, PTC, FAO, ACC, PA, FASN, SREBP, ChREBP, PPAR, ER, OS, ROS, OXPHOS
Keywords : Lipotoxicity, Lipid overload, Acute kidney injury, Chronic kidney disease, Molecular mechanism
Plan
Vol 161
Article 114465- mai 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?